Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III

M Haude; H (Huseyin) Ince; S Kische; A Abizaid; R Tolg; PA Lemos; Nicolas van Mieghem; S Verheye; C von Birgelen; EH Christiansen; E Barbato; HM Garcia Garcia; R Waksman

doi:10.1002/ccd.27680

Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III

M Haude, H (Huseyin) Ince, S Kische, A Abizaid, R Tolg, PA Lemos, Nicolas van Mieghem, S Verheye, C von Birgelen, EH Christiansen, E Barbato, HM Garcia Garcia, R Waksman

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

61 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E502-E511
Journal	Catheterization and Cardiovascular Interventions
Volume	92
Issue number	7
DOIs	https://doi.org/10.1002/ccd.27680
Publication status	Published - 2018

Research programs

EMC COEUR-09

Access to Document

10.1002/ccd.27680

Cite this

Haude, M., Ince, H., Kische, S., Abizaid, A., Tolg, R., Lemos, PA., van Mieghem, N., Verheye, S., von Birgelen, C., Christiansen, EH., Barbato, E., Garcia Garcia, HM., & Waksman, R. (2018). Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. Catheterization and Cardiovascular Interventions, 92(7), E502-E511. https://doi.org/10.1002/ccd.27680

@article{2ecbbee0b9554ae3913922cb19c9a141,

title = "Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III",

author = "M Haude and Ince, {H (Huseyin)} and S Kische and A Abizaid and R Tolg and PA Lemos and {van Mieghem}, Nicolas and S Verheye and {von Birgelen}, C and EH Christiansen and E Barbato and {Garcia Garcia}, HM and R Waksman",

year = "2018",

doi = "10.1002/ccd.27680",

language = "Undefined/Unknown",

volume = "92",

pages = "E502--E511",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "John Wiley & Sons Inc.",

number = "7",

}

Haude, M, Ince, H, Kische, S, Abizaid, A, Tolg, R, Lemos, PA, van Mieghem, N, Verheye, S, von Birgelen, C, Christiansen, EH, Barbato, E, Garcia Garcia, HM & Waksman, R 2018, 'Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III', Catheterization and Cardiovascular Interventions, vol. 92, no. 7, pp. E502-E511. https://doi.org/10.1002/ccd.27680

Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. / Haude, M; Ince, H (Huseyin); Kische, S et al.
In: Catheterization and Cardiovascular Interventions, Vol. 92, No. 7, 2018, p. E502-E511.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III

AU - Haude, M

AU - Ince, H (Huseyin)

AU - Kische, S

AU - Abizaid, A

AU - Tolg, R

AU - Lemos, PA

AU - van Mieghem, Nicolas

AU - Verheye, S

AU - von Birgelen, C

AU - Christiansen, EH

AU - Barbato, E

AU - Garcia Garcia, HM

AU - Waksman, R

PY - 2018

Y1 - 2018

U2 - 10.1002/ccd.27680

DO - 10.1002/ccd.27680

M3 - Article

C2 - 30079472

SN - 1522-1946

VL - 92

SP - E502-E511

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - 7

ER -